

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neuronal action potential propagation (GO:0019227) | 6.25499064 |
| 2 | glutamate secretion (GO:0014047) | 6.18524784 |
| 3 | synaptic vesicle exocytosis (GO:0016079) | 6.13744104 |
| 4 | synaptic vesicle maturation (GO:0016188) | 5.89150796 |
| 5 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.78612843 |
| 6 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.49396773 |
| 7 | negative regulation of dendrite morphogenesis (GO:0050774) | 5.44675992 |
| 8 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.07417371 |
| 9 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.89277487 |
| 10 | regulation of synaptic vesicle transport (GO:1902803) | 4.84249111 |
| 11 | locomotory exploration behavior (GO:0035641) | 4.72869237 |
| 12 | vocalization behavior (GO:0071625) | 4.61679538 |
| 13 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.60849892 |
| 14 | protein localization to synapse (GO:0035418) | 4.57775835 |
| 15 | neuron cell-cell adhesion (GO:0007158) | 4.42646815 |
| 16 | cell migration in hindbrain (GO:0021535) | 4.36826697 |
| 17 | cerebellar Purkinje cell differentiation (GO:0021702) | 4.31233378 |
| 18 | neurotransmitter secretion (GO:0007269) | 4.29857857 |
| 19 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.26191193 |
| 20 | negative regulation of dendrite development (GO:2000171) | 4.12106786 |
| 21 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 4.09947672 |
| 22 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.01472203 |
| 23 | proline biosynthetic process (GO:0006561) | 4.00452680 |
| 24 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.99834499 |
| 25 | neuromuscular process controlling posture (GO:0050884) | 3.99693871 |
| 26 | membrane depolarization during action potential (GO:0086010) | 3.96595347 |
| 27 | proline transport (GO:0015824) | 3.95627732 |
| 28 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.93505990 |
| 29 | exploration behavior (GO:0035640) | 3.92712549 |
| 30 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.89644249 |
| 31 | NADH metabolic process (GO:0006734) | 3.85778510 |
| 32 | neuron-neuron synaptic transmission (GO:0007270) | 3.79975802 |
| 33 | synaptic transmission, glutamatergic (GO:0035249) | 3.79133276 |
| 34 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.77974842 |
| 35 | neurofilament cytoskeleton organization (GO:0060052) | 3.77339136 |
| 36 | creatine metabolic process (GO:0006600) | 3.70412776 |
| 37 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.68850580 |
| 38 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.63964693 |
| 39 | proline metabolic process (GO:0006560) | 3.63653862 |
| 40 | cellular potassium ion homeostasis (GO:0030007) | 3.61581523 |
| 41 | innervation (GO:0060384) | 3.59912030 |
| 42 | regulation of neurotransmitter secretion (GO:0046928) | 3.58246688 |
| 43 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.58150214 |
| 44 | muscle filament sliding (GO:0030049) | 3.57264597 |
| 45 | actin-myosin filament sliding (GO:0033275) | 3.57264597 |
| 46 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.51433735 |
| 47 | neurotransmitter transport (GO:0006836) | 3.49174929 |
| 48 | gamma-aminobutyric acid transport (GO:0015812) | 3.45221199 |
| 49 | negative regulation of cell size (GO:0045792) | 3.44199553 |
| 50 | glutamate receptor signaling pathway (GO:0007215) | 3.42954978 |
| 51 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 3.42124462 |
| 52 | gluconeogenesis (GO:0006094) | 3.40336647 |
| 53 | regulation of synaptic plasticity (GO:0048167) | 3.40036358 |
| 54 | calcium ion-dependent exocytosis (GO:0017156) | 3.37605747 |
| 55 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.37020680 |
| 56 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.35878508 |
| 57 | activation of protein kinase A activity (GO:0034199) | 3.33597041 |
| 58 | synaptic vesicle endocytosis (GO:0048488) | 3.31897806 |
| 59 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.30424567 |
| 60 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.29426223 |
| 61 | regulation of neurotransmitter levels (GO:0001505) | 3.27786071 |
| 62 | regulation of synapse structural plasticity (GO:0051823) | 3.27231130 |
| 63 | Golgi transport vesicle coating (GO:0048200) | 3.26993928 |
| 64 | COPI coating of Golgi vesicle (GO:0048205) | 3.26993928 |
| 65 | L-phenylalanine metabolic process (GO:0006558) | 3.25597490 |
| 66 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.25597490 |
| 67 | negative regulation of microtubule polymerization (GO:0031115) | 3.25083395 |
| 68 | membrane depolarization (GO:0051899) | 3.24649758 |
| 69 | hexose biosynthetic process (GO:0019319) | 3.23308413 |
| 70 | cell-substrate adherens junction assembly (GO:0007045) | 3.22770078 |
| 71 | focal adhesion assembly (GO:0048041) | 3.22770078 |
| 72 | long-term synaptic potentiation (GO:0060291) | 3.21297579 |
| 73 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.20765387 |
| 74 | regulation of postsynaptic membrane potential (GO:0060078) | 3.20671431 |
| 75 | protein retention in ER lumen (GO:0006621) | 3.19499191 |
| 76 | positive regulation of membrane potential (GO:0045838) | 3.19217576 |
| 77 | regulation of neurotransmitter transport (GO:0051588) | 3.19071657 |
| 78 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.16340542 |
| 79 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.16097374 |
| 80 | neuronal action potential (GO:0019228) | 3.15853245 |
| 81 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.15766321 |
| 82 | adherens junction assembly (GO:0034333) | 3.15711062 |
| 83 | regulation of vesicle fusion (GO:0031338) | 3.14701451 |
| 84 | cell communication by electrical coupling (GO:0010644) | 3.13588000 |
| 85 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 3.13291345 |
| 86 | sodium ion export (GO:0071436) | 3.11240651 |
| 87 | cardiac muscle contraction (GO:0060048) | 3.10068109 |
| 88 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.06340255 |
| 89 | synaptic transmission (GO:0007268) | 3.05856339 |
| 90 | neuromuscular process (GO:0050905) | 3.04435919 |
| 91 | monosaccharide biosynthetic process (GO:0046364) | 3.04273176 |
| 92 | neuromuscular process controlling balance (GO:0050885) | 3.04069144 |
| 93 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.03655884 |
| 94 | vesicle transport along microtubule (GO:0047496) | 3.03505168 |
| 95 | negative regulation of cation channel activity (GO:2001258) | 3.03018796 |
| 96 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 3.02782988 |
| 97 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 3.02782988 |
| 98 | 4-hydroxyproline metabolic process (GO:0019471) | 3.00766459 |
| 99 | peripheral nervous system neuron development (GO:0048935) | 3.00174238 |
| 100 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.99878238 |
| 101 | membrane repolarization (GO:0086009) | 2.99539131 |
| 102 | neuron recognition (GO:0008038) | 2.99460107 |
| 103 | synaptic vesicle transport (GO:0048489) | 2.98675477 |
| 104 | establishment of synaptic vesicle localization (GO:0097480) | 2.98675477 |
| 105 | layer formation in cerebral cortex (GO:0021819) | 2.98446275 |
| 106 | urea cycle (GO:0000050) | 2.97614686 |
| 107 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.97496303 |
| 108 | protein carboxylation (GO:0018214) | 2.97496303 |
| 109 | mating behavior (GO:0007617) | 2.95848768 |
| 110 | oxaloacetate metabolic process (GO:0006107) | 2.95665313 |
| 111 | neuromuscular synaptic transmission (GO:0007274) | 2.94920421 |
| 112 | positive regulation of synapse maturation (GO:0090129) | 2.94673203 |
| 113 | sarcomere organization (GO:0045214) | 2.93859630 |
| 114 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.93093544 |
| 115 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.93093544 |
| 116 | transferrin transport (GO:0033572) | 2.92935063 |
| 117 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.92361804 |
| 118 | presynaptic membrane assembly (GO:0097105) | 2.89824127 |
| 119 | regulation of synaptic transmission (GO:0050804) | 2.89753902 |
| 120 | presynaptic membrane organization (GO:0097090) | 2.89245015 |
| 121 | membrane hyperpolarization (GO:0060081) | 2.89161795 |
| 122 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.89082151 |
| 123 | organelle transport along microtubule (GO:0072384) | 2.88531891 |
| 124 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.88302671 |
| 125 | detection of temperature stimulus (GO:0016048) | 2.88124695 |
| 126 | regulation of cholesterol metabolic process (GO:0090181) | 2.87161727 |
| 127 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.86931567 |
| 128 | inositol phosphate catabolic process (GO:0071545) | 2.85838991 |
| 129 | adult walking behavior (GO:0007628) | 2.85165840 |
| 130 | synapse assembly (GO:0007416) | 2.85061142 |
| 131 | 2-oxoglutarate metabolic process (GO:0006103) | 2.84963802 |
| 132 | establishment of vesicle localization (GO:0051650) | 2.84462211 |
| 133 | striated muscle contraction (GO:0006941) | 2.84236704 |
| 134 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.82287319 |
| 135 | cardiac myofibril assembly (GO:0055003) | 2.78901594 |
| 136 | urea metabolic process (GO:0019627) | 2.75475188 |
| 137 | actin-mediated cell contraction (GO:0070252) | 2.75315867 |
| 138 | biotin metabolic process (GO:0006768) | 2.75214020 |
| 139 | L-phenylalanine catabolic process (GO:0006559) | 2.70379836 |
| 140 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.70379836 |
| 141 | skeletal muscle contraction (GO:0003009) | 2.70377480 |
| 142 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.68309039 |
| 143 | lung epithelium development (GO:0060428) | 2.67356899 |
| 144 | regulation of synapse maturation (GO:0090128) | 2.66964231 |
| 145 | tricarboxylic acid metabolic process (GO:0072350) | 2.66802364 |
| 146 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.65086148 |
| 147 | basement membrane organization (GO:0071711) | 2.65062667 |
| 148 | fructose metabolic process (GO:0006000) | 2.63446739 |
| 149 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.61926348 |
| 150 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.60808559 |
| 151 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.57748029 |
| 152 | myofibril assembly (GO:0030239) | 2.57677016 |
| 153 | regulation of cholesterol homeostasis (GO:2000188) | 2.56579637 |
| 154 | nitrogen cycle metabolic process (GO:0071941) | 2.55226401 |
| 155 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.47493591 |
| 156 | semaphorin-plexin signaling pathway (GO:0071526) | 2.44553644 |
| 157 | regulation of translational fidelity (GO:0006450) | 2.43401835 |
| 158 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.42736926 |
| 159 | tricarboxylic acid cycle (GO:0006099) | 2.42726440 |
| 160 | cell-cell junction maintenance (GO:0045217) | 2.41991899 |
| 161 | glycolytic process (GO:0006096) | 2.41014139 |
| 162 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.38056095 |
| 163 | cerebellar Purkinje cell layer development (GO:0021680) | 2.36010823 |
| 164 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.34267923 |
| 165 | cerebellar granule cell differentiation (GO:0021707) | 2.33948432 |
| 166 | glycogen catabolic process (GO:0005980) | 2.32774109 |
| 167 | phosphate ion transmembrane transport (GO:0035435) | 2.32567329 |
| 168 | GDP-mannose metabolic process (GO:0019673) | 2.32301636 |
| 169 | cellular modified amino acid catabolic process (GO:0042219) | 2.32029979 |
| 170 | apoptotic process involved in morphogenesis (GO:0060561) | 2.30275417 |
| 171 | response to parathyroid hormone (GO:0071107) | 2.29579473 |
| 172 | actomyosin structure organization (GO:0031032) | 2.29035978 |
| 173 | glutamate metabolic process (GO:0006536) | 2.26866608 |
| 174 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.26862706 |
| 175 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.25902828 |
| 176 | mannose metabolic process (GO:0006013) | 2.25262224 |
| 177 | skeletal muscle fiber development (GO:0048741) | 2.23423693 |
| 178 | maternal placenta development (GO:0001893) | 2.22909144 |
| 179 | respiratory system process (GO:0003016) | 2.22724878 |
| 180 | glucose 6-phosphate metabolic process (GO:0051156) | 2.21889799 |
| 181 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.20679679 |
| 182 | atrioventricular valve morphogenesis (GO:0003181) | 2.17976175 |
| 183 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.17550155 |
| 184 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.17417276 |
| 185 | regulation of skeletal muscle contraction (GO:0014819) | 2.15911096 |
| 186 | negative regulation of fibrinolysis (GO:0051918) | 2.15036090 |
| 187 | alpha-linolenic acid metabolic process (GO:0036109) | 2.14608566 |
| 188 | endothelial cell chemotaxis (GO:0035767) | 2.14185503 |
| 189 | carnitine shuttle (GO:0006853) | 2.13926936 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.93446504 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.86035053 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.25605962 |
| 4 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 3.23483376 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.08207190 |
| 6 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.03935015 |
| 7 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.96614750 |
| 8 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.95194269 |
| 9 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.90492235 |
| 10 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.84775492 |
| 11 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.81721993 |
| 12 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.81721993 |
| 13 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.77716032 |
| 14 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.72269384 |
| 15 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.69815303 |
| 16 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.67243976 |
| 17 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.58584294 |
| 18 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.58251670 |
| 19 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.56583876 |
| 20 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.51544023 |
| 21 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.49979503 |
| 22 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.44595452 |
| 23 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.43313217 |
| 24 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.41078852 |
| 25 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.39372161 |
| 26 | RACK7_27058665_Chip-Seq_MCF-7_Human | 2.38814818 |
| 27 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.35315938 |
| 28 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.33157342 |
| 29 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.18398000 |
| 30 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.17815909 |
| 31 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.15168366 |
| 32 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.15018728 |
| 33 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.11727766 |
| 34 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.08243360 |
| 35 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 2.01929328 |
| 36 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.95567047 |
| 37 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.93998051 |
| 38 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.91935526 |
| 39 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.90737254 |
| 40 | P68_20966046_ChIP-Seq_HELA_Human | 1.89248377 |
| 41 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.85434622 |
| 42 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.84813876 |
| 43 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.83604114 |
| 44 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.81757795 |
| 45 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.80796849 |
| 46 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.80787068 |
| 47 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.80613384 |
| 48 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.76842165 |
| 49 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.75986582 |
| 50 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.75725626 |
| 51 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.74812406 |
| 52 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.74419334 |
| 53 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.72477584 |
| 54 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.69824197 |
| 55 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.68859928 |
| 56 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.67704871 |
| 57 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.67172827 |
| 58 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.65216439 |
| 59 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.64956096 |
| 60 | P300_19829295_ChIP-Seq_ESCs_Human | 1.62078427 |
| 61 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.61055943 |
| 62 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.60789934 |
| 63 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.59150284 |
| 64 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.57561442 |
| 65 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.57435504 |
| 66 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.57152620 |
| 67 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.56322387 |
| 68 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.55344564 |
| 69 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.54105922 |
| 70 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.52853436 |
| 71 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.52611013 |
| 72 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.51901512 |
| 73 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.50539925 |
| 74 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.49583008 |
| 75 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.48627641 |
| 76 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.48132954 |
| 77 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.46543463 |
| 78 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.46155046 |
| 79 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.44869407 |
| 80 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.44018270 |
| 81 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.42968610 |
| 82 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.42723213 |
| 83 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.41327024 |
| 84 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.41080811 |
| 85 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.39917094 |
| 86 | * SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.39747387 |
| 87 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.39004508 |
| 88 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.36767827 |
| 89 | AR_25329375_ChIP-Seq_VCAP_Human | 1.35509620 |
| 90 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.35484387 |
| 91 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.35457579 |
| 92 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.34461835 |
| 93 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.33064125 |
| 94 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.32960889 |
| 95 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.31370610 |
| 96 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.30833478 |
| 97 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.30292999 |
| 98 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.29228719 |
| 99 | MYC_22102868_ChIP-Seq_BL_Human | 1.27132871 |
| 100 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.27080764 |
| 101 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.26814087 |
| 102 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.25806810 |
| 103 | STAT3_23295773_ChIP-Seq_U87_Human | 1.25709434 |
| 104 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.25604783 |
| 105 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.25289894 |
| 106 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.22847347 |
| 107 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.22546122 |
| 108 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.22319256 |
| 109 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.21627205 |
| 110 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.19686126 |
| 111 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.19447338 |
| 112 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.19198335 |
| 113 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.18926675 |
| 114 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.18722673 |
| 115 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.18293570 |
| 116 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.18100646 |
| 117 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.18086966 |
| 118 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.17930236 |
| 119 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.17370586 |
| 120 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.17254466 |
| 121 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.16834196 |
| 122 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.16292059 |
| 123 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.14747977 |
| 124 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.13763917 |
| 125 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.12458191 |
| 126 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.11700151 |
| 127 | AR_19668381_ChIP-Seq_PC3_Human | 1.10815570 |
| 128 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.09992426 |
| 129 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.09881989 |
| 130 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.09392531 |
| 131 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.09067475 |
| 132 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.08986111 |
| 133 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.08850918 |
| 134 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.08836233 |
| 135 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.08265779 |
| 136 | TCF4_23295773_ChIP-Seq_U87_Human | 1.08244412 |
| 137 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.07096022 |
| 138 | ATF3_27146783_Chip-Seq_COLON_Human | 1.07073062 |
| 139 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.06922451 |
| 140 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.04883984 |
| 141 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.04717043 |
| 142 | SA1_27219007_Chip-Seq_Bcells_Human | 1.04481715 |
| 143 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04242053 |
| 144 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.03924870 |
| 145 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.01753187 |
| 146 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.01452469 |
| 147 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.01345890 |
| 148 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.01088453 |
| 149 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.00563209 |
| 150 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.00327325 |
| 151 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.00278946 |
| 152 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.00250150 |
| 153 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.00190893 |
| 154 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.00019199 |
| 155 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.99771800 |
| 156 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.99479306 |
| 157 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.99448622 |
| 158 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.99188312 |
| 159 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.99188312 |
| 160 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.98741058 |
| 161 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.98720780 |
| 162 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98542258 |
| 163 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.98265307 |
| 164 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.98005086 |
| 165 | JUN_21703547_ChIP-Seq_K562_Human | 0.97475603 |
| 166 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.96786061 |
| 167 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.95393780 |
| 168 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.95147263 |
| 169 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.95031262 |
| 170 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.94755388 |
| 171 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.92044961 |
| 172 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.91948267 |
| 173 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.91860635 |
| 174 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.90861181 |
| 175 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.90658666 |
| 176 | VDR_22108803_ChIP-Seq_LS180_Human | 0.89377596 |
| 177 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.88886514 |
| 178 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.87542665 |
| 179 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.86897512 |
| 180 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.86553187 |
| 181 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.86553187 |
| 182 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.86457223 |
| 183 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.86326213 |
| 184 | * KDM2B_26808549_Chip-Seq_K562_Human | 0.85969513 |
| 185 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.85807002 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.65247228 |
| 2 | MP0003880_abnormal_central_pattern | 4.88764354 |
| 3 | MP0004270_analgesia | 4.15836096 |
| 4 | MP0002735_abnormal_chemical_nociception | 3.94328628 |
| 5 | MP0001968_abnormal_touch/_nociception | 3.87974576 |
| 6 | MP0003635_abnormal_synaptic_transmissio | 3.76564839 |
| 7 | MP0005451_abnormal_body_composition | 3.60583731 |
| 8 | MP0002736_abnormal_nociception_after | 3.37885891 |
| 9 | MP0009046_muscle_twitch | 3.37186243 |
| 10 | MP0002734_abnormal_mechanical_nocicepti | 3.20398457 |
| 11 | MP0002064_seizures | 3.11384187 |
| 12 | MP0003705_abnormal_hypodermis_morpholog | 3.05632371 |
| 13 | MP0009745_abnormal_behavioral_response | 3.00289616 |
| 14 | MP0002063_abnormal_learning/memory/cond | 2.88675971 |
| 15 | MP0002272_abnormal_nervous_system | 2.76322653 |
| 16 | MP0002733_abnormal_thermal_nociception | 2.67852634 |
| 17 | MP0004858_abnormal_nervous_system | 2.61053789 |
| 18 | MP0002572_abnormal_emotion/affect_behav | 2.53358396 |
| 19 | MP0001970_abnormal_pain_threshold | 2.53192859 |
| 20 | MP0001486_abnormal_startle_reflex | 2.36460388 |
| 21 | MP0006276_abnormal_autonomic_nervous | 2.35710245 |
| 22 | MP0002067_abnormal_sensory_capabilities | 2.25521831 |
| 23 | MP0004036_abnormal_muscle_relaxation | 2.23529701 |
| 24 | MP0001984_abnormal_olfaction | 2.20850594 |
| 25 | MP0002184_abnormal_innervation | 2.20357871 |
| 26 | MP0005360_urolithiasis | 2.16888109 |
| 27 | MP0000747_muscle_weakness | 2.16418418 |
| 28 | MP0001440_abnormal_grooming_behavior | 2.08809710 |
| 29 | MP0004087_abnormal_muscle_fiber | 2.05774271 |
| 30 | MP0003123_paternal_imprinting | 2.05251959 |
| 31 | MP0005423_abnormal_somatic_nervous | 2.03928082 |
| 32 | MP0001501_abnormal_sleep_pattern | 2.01273981 |
| 33 | MP0002249_abnormal_larynx_morphology | 2.01046374 |
| 34 | MP0010030_abnormal_orbit_morphology | 1.99656149 |
| 35 | MP0005330_cardiomyopathy | 1.97678227 |
| 36 | MP0004084_abnormal_cardiac_muscle | 1.94648472 |
| 37 | MP0005058_abnormal_lysosome_morphology | 1.93804317 |
| 38 | MP0008569_lethality_at_weaning | 1.91501797 |
| 39 | MP0000759_abnormal_skeletal_muscle | 1.91202966 |
| 40 | MP0005409_darkened_coat_color | 1.90638242 |
| 41 | MP0003329_amyloid_beta_deposits | 1.84839358 |
| 42 | MP0004811_abnormal_neuron_physiology | 1.84172245 |
| 43 | MP0001346_abnormal_lacrimal_gland | 1.83782027 |
| 44 | MP0002269_muscular_atrophy | 1.78825664 |
| 45 | MP0000750_abnormal_muscle_regeneration | 1.78496427 |
| 46 | MP0009840_abnormal_foam_cell | 1.77584050 |
| 47 | MP0002822_catalepsy | 1.76927455 |
| 48 | MP0000955_abnormal_spinal_cord | 1.75624301 |
| 49 | MP0005670_abnormal_white_adipose | 1.72510248 |
| 50 | MP0005386_behavior/neurological_phenoty | 1.69067155 |
| 51 | MP0004924_abnormal_behavior | 1.69067155 |
| 52 | MP0000003_abnormal_adipose_tissue | 1.68604221 |
| 53 | MP0003879_abnormal_hair_cell | 1.63866425 |
| 54 | MP0004185_abnormal_adipocyte_glucose | 1.62708608 |
| 55 | MP0000733_abnormal_muscle_development | 1.61400002 |
| 56 | MP0000778_abnormal_nervous_system | 1.59865499 |
| 57 | MP0002557_abnormal_social/conspecific_i | 1.54551097 |
| 58 | MP0002106_abnormal_muscle_physiology | 1.51524406 |
| 59 | MP0005666_abnormal_adipose_tissue | 1.51096113 |
| 60 | MP0003183_abnormal_peptide_metabolism | 1.50884297 |
| 61 | MP0004142_abnormal_muscle_tone | 1.49591878 |
| 62 | MP0002882_abnormal_neuron_morphology | 1.49435840 |
| 63 | MP0001905_abnormal_dopamine_level | 1.46643228 |
| 64 | MP0005083_abnormal_biliary_tract | 1.44854156 |
| 65 | MP0010630_abnormal_cardiac_muscle | 1.43925012 |
| 66 | MP0002066_abnormal_motor_capabilities/c | 1.39078136 |
| 67 | MP0002089_abnormal_postnatal_growth/wei | 1.38349173 |
| 68 | MP0006138_congestive_heart_failure | 1.37016851 |
| 69 | MP0005646_abnormal_pituitary_gland | 1.36860331 |
| 70 | MP0000566_synostosis | 1.35123058 |
| 71 | MP0004130_abnormal_muscle_cell | 1.34808506 |
| 72 | MP0005369_muscle_phenotype | 1.34433823 |
| 73 | MP0001986_abnormal_taste_sensitivity | 1.32725649 |
| 74 | MP0005375_adipose_tissue_phenotype | 1.32491635 |
| 75 | MP0001529_abnormal_vocalization | 1.26409861 |
| 76 | MP0000678_abnormal_parathyroid_gland | 1.26290505 |
| 77 | MP0000013_abnormal_adipose_tissue | 1.25465584 |
| 78 | MP0003137_abnormal_impulse_conducting | 1.24746120 |
| 79 | MP0009780_abnormal_chondrocyte_physiolo | 1.24645525 |
| 80 | MP0003633_abnormal_nervous_system | 1.21730145 |
| 81 | MP0003787_abnormal_imprinting | 1.21703957 |
| 82 | MP0005076_abnormal_cell_differentiation | 1.21098113 |
| 83 | MP0003122_maternal_imprinting | 1.17019543 |
| 84 | MP0002229_neurodegeneration | 1.16168385 |
| 85 | MP0002972_abnormal_cardiac_muscle | 1.16131724 |
| 86 | MP0001661_extended_life_span | 1.14198794 |
| 87 | MP0002909_abnormal_adrenal_gland | 1.14083854 |
| 88 | MP0001849_ear_inflammation | 1.13971612 |
| 89 | MP0002108_abnormal_muscle_morphology | 1.10486986 |
| 90 | MP0000751_myopathy | 1.10020378 |
| 91 | MP0005620_abnormal_muscle_contractility | 1.09452223 |
| 92 | MP0003631_nervous_system_phenotype | 1.07548048 |
| 93 | MP0001502_abnormal_circadian_rhythm | 1.05618641 |
| 94 | MP0002751_abnormal_autonomic_nervous | 1.02451281 |
| 95 | MP0005365_abnormal_bile_salt | 1.01106285 |
| 96 | MP0002152_abnormal_brain_morphology | 0.98515769 |
| 97 | MP0001963_abnormal_hearing_physiology | 0.98353863 |
| 98 | MP0008260_abnormal_autophagy | 0.97127698 |
| 99 | MP0002752_abnormal_somatic_nervous | 0.96539760 |
| 100 | MP0008872_abnormal_physiological_respon | 0.95721364 |
| 101 | MP0004742_abnormal_vestibular_system | 0.95191104 |
| 102 | MP0001188_hyperpigmentation | 0.94607682 |
| 103 | MP0004145_abnormal_muscle_electrophysio | 0.92952558 |
| 104 | MP0004885_abnormal_endolymph | 0.92819478 |
| 105 | MP0008874_decreased_physiological_sensi | 0.92510762 |
| 106 | MP0004510_myositis | 0.92356634 |
| 107 | MP0000537_abnormal_urethra_morphology | 0.91545077 |
| 108 | MP0003634_abnormal_glial_cell | 0.89539795 |
| 109 | MP0003942_abnormal_urinary_system | 0.89267060 |
| 110 | MP0010234_abnormal_vibrissa_follicle | 0.88551079 |
| 111 | MP0001485_abnormal_pinna_reflex | 0.88272231 |
| 112 | MP0008438_abnormal_cutaneous_collagen | 0.87861523 |
| 113 | MP0009384_cardiac_valve_regurgitation | 0.85286945 |
| 114 | MP0000604_amyloidosis | 0.84742214 |
| 115 | MP0004147_increased_porphyrin_level | 0.84279549 |
| 116 | MP0005645_abnormal_hypothalamus_physiol | 0.82444096 |
| 117 | MP0010329_abnormal_lipoprotein_level | 0.82341926 |
| 118 | MP0002653_abnormal_ependyma_morphology | 0.81842570 |
| 119 | MP0005410_abnormal_fertilization | 0.81497859 |
| 120 | MP0004085_abnormal_heartbeat | 0.80190562 |
| 121 | MP0005499_abnormal_olfactory_system | 0.78994531 |
| 122 | MP0005394_taste/olfaction_phenotype | 0.78994531 |
| 123 | MP0003566_abnormal_cell_adhesion | 0.77972645 |
| 124 | MP0002069_abnormal_eating/drinking_beha | 0.77551536 |
| 125 | MP0002837_dystrophic_cardiac_calcinosis | 0.76818569 |
| 126 | MP0000534_abnormal_ureter_morphology | 0.76774225 |
| 127 | MP0005171_absent_coat_pigmentation | 0.75034950 |
| 128 | MP0002139_abnormal_hepatobiliary_system | 0.74492256 |
| 129 | MP0009672_abnormal_birth_weight | 0.73603117 |
| 130 | MP0001664_abnormal_digestion | 0.73387386 |
| 131 | MP0003632_abnormal_nervous_system | 0.73122364 |
| 132 | MP0002971_abnormal_brown_adipose | 0.71745240 |
| 133 | MP0005332_abnormal_amino_acid | 0.71551075 |
| 134 | MP0005535_abnormal_body_temperature | 0.71296678 |
| 135 | MP0000681_abnormal_thyroid_gland | 0.70763883 |
| 136 | MP0006036_abnormal_mitochondrial_physio | 0.69910380 |
| 137 | MP0003172_abnormal_lysosome_physiology | 0.69625450 |
| 138 | MP0002876_abnormal_thyroid_physiology | 0.68316898 |
| 139 | MP0000920_abnormal_myelination | 0.68032246 |
| 140 | MP0008775_abnormal_heart_ventricle | 0.65228148 |
| 141 | MP0008877_abnormal_DNA_methylation | 0.64964924 |
| 142 | MP0004272_abnormal_basement_membrane | 0.64722506 |
| 143 | MP0002118_abnormal_lipid_homeostasis | 0.64585332 |
| 144 | MP0005623_abnormal_meninges_morphology | 0.64003911 |
| 145 | MP0001544_abnormal_cardiovascular_syste | 0.62847349 |
| 146 | MP0005385_cardiovascular_system_phenoty | 0.62847349 |
| 147 | MP0005551_abnormal_eye_electrophysiolog | 0.62439969 |
| 148 | MP0001299_abnormal_eye_distance/ | 0.61363465 |
| 149 | MP0004215_abnormal_myocardial_fiber | 0.61010559 |
| 150 | MP0004264_abnormal_extraembryonic_tissu | 0.60637797 |
| 151 | MP0001666_abnormal_nutrient_absorption | 0.59901932 |
| 152 | MP0002163_abnormal_gland_morphology | 0.59712229 |
| 153 | MP0002160_abnormal_reproductive_system | 0.59452409 |
| 154 | MP0001177_atelectasis | 0.59198393 |
| 155 | MP0000749_muscle_degeneration | 0.58995738 |
| 156 | MP0001348_abnormal_lacrimal_gland | 0.58646834 |
| 157 | MP0004484_altered_response_of | 0.58472996 |
| 158 | MP0000639_abnormal_adrenal_gland | 0.58261673 |
| 159 | MP0001943_abnormal_respiration | 0.56939648 |
| 160 | MP0003385_abnormal_body_wall | 0.56732259 |
| 161 | MP0003115_abnormal_respiratory_system | 0.56396005 |
| 162 | MP0010769_abnormal_survival | 0.52919456 |
| 163 | MP0004233_abnormal_muscle_weight | 0.52890969 |
| 164 | MP0010770_preweaning_lethality | 0.52211606 |
| 165 | MP0002082_postnatal_lethality | 0.52211606 |
| 166 | MP0003646_muscle_fatigue | 0.51751352 |
| 167 | MP0003956_abnormal_body_size | 0.50880804 |
| 168 | MP0010768_mortality/aging | 0.49939374 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 7.46533928 |
| 2 | Focal motor seizures (HP:0011153) | 7.45746424 |
| 3 | Atonic seizures (HP:0010819) | 6.05913886 |
| 4 | Focal seizures (HP:0007359) | 5.78540309 |
| 5 | Febrile seizures (HP:0002373) | 5.51948058 |
| 6 | Epileptic encephalopathy (HP:0200134) | 4.85758644 |
| 7 | Progressive cerebellar ataxia (HP:0002073) | 4.73471219 |
| 8 | Action tremor (HP:0002345) | 4.61892348 |
| 9 | Absence seizures (HP:0002121) | 4.46283269 |
| 10 | Visual hallucinations (HP:0002367) | 4.32490248 |
| 11 | Exercise-induced myalgia (HP:0003738) | 4.16182526 |
| 12 | Dialeptic seizures (HP:0011146) | 4.11633873 |
| 13 | Pheochromocytoma (HP:0002666) | 4.03576305 |
| 14 | Generalized tonic-clonic seizures (HP:0002069) | 3.90340410 |
| 15 | Ulnar claw (HP:0001178) | 3.84253486 |
| 16 | Myopathic facies (HP:0002058) | 3.82297537 |
| 17 | Muscle fiber inclusion bodies (HP:0100299) | 3.80732178 |
| 18 | Neuroendocrine neoplasm (HP:0100634) | 3.79230443 |
| 19 | Type 1 muscle fiber predominance (HP:0003803) | 3.74372574 |
| 20 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.71479116 |
| 21 | Nemaline bodies (HP:0003798) | 3.63985734 |
| 22 | Deep venous thrombosis (HP:0002625) | 3.57031915 |
| 23 | Distal lower limb muscle weakness (HP:0009053) | 3.46635848 |
| 24 | Gaze-evoked nystagmus (HP:0000640) | 3.42482553 |
| 25 | Insidious onset (HP:0003587) | 3.42480800 |
| 26 | Termporal pattern (HP:0011008) | 3.42480800 |
| 27 | Ankle clonus (HP:0011448) | 3.21606028 |
| 28 | Truncal ataxia (HP:0002078) | 3.20552999 |
| 29 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.20340463 |
| 30 | Supranuclear gaze palsy (HP:0000605) | 3.19321733 |
| 31 | Increased connective tissue (HP:0009025) | 3.01456827 |
| 32 | Hyporeflexia of lower limbs (HP:0002600) | 2.97712921 |
| 33 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.96666658 |
| 34 | Limb dystonia (HP:0002451) | 2.95952685 |
| 35 | Distal lower limb amyotrophy (HP:0008944) | 2.95757313 |
| 36 | Amblyopia (HP:0000646) | 2.91443998 |
| 37 | Sudden death (HP:0001699) | 2.90530786 |
| 38 | Hyperventilation (HP:0002883) | 2.85812274 |
| 39 | Abnormality of the lower motor neuron (HP:0002366) | 2.85224250 |
| 40 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.80662549 |
| 41 | Exercise-induced muscle cramps (HP:0003710) | 2.80411407 |
| 42 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.77309188 |
| 43 | Bundle branch block (HP:0011710) | 2.74724530 |
| 44 | Abnormality of the Achilles tendon (HP:0005109) | 2.72971811 |
| 45 | Asymmetric septal hypertrophy (HP:0001670) | 2.69713580 |
| 46 | Achilles tendon contracture (HP:0001771) | 2.65339986 |
| 47 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.61362512 |
| 48 | Scanning speech (HP:0002168) | 2.58968203 |
| 49 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.58580513 |
| 50 | Myoglobinuria (HP:0002913) | 2.58274999 |
| 51 | Hyperacusis (HP:0010780) | 2.58148615 |
| 52 | Round ear (HP:0100830) | 2.58065724 |
| 53 | Depression (HP:0000716) | 2.57958819 |
| 54 | Urinary urgency (HP:0000012) | 2.56354066 |
| 55 | Abnormal eating behavior (HP:0100738) | 2.55093157 |
| 56 | EMG: myopathic abnormalities (HP:0003458) | 2.53945862 |
| 57 | Failure to thrive in infancy (HP:0001531) | 2.53687122 |
| 58 | Broad-based gait (HP:0002136) | 2.52502659 |
| 59 | Rhabdomyolysis (HP:0003201) | 2.50009549 |
| 60 | Impaired smooth pursuit (HP:0007772) | 2.46708956 |
| 61 | Dysmetria (HP:0001310) | 2.45545928 |
| 62 | Cerebral aneurysm (HP:0004944) | 2.45335350 |
| 63 | Poor eye contact (HP:0000817) | 2.43693526 |
| 64 | Reticulocytosis (HP:0001923) | 2.41796755 |
| 65 | Fetal akinesia sequence (HP:0001989) | 2.40452858 |
| 66 | Anxiety (HP:0000739) | 2.40082040 |
| 67 | Spastic gait (HP:0002064) | 2.39591930 |
| 68 | Increased variability in muscle fiber diameter (HP:0003557) | 2.39135703 |
| 69 | Dysdiadochokinesis (HP:0002075) | 2.38232310 |
| 70 | Difficulty climbing stairs (HP:0003551) | 2.38219016 |
| 71 | Abnormal atrioventricular conduction (HP:0005150) | 2.37659191 |
| 72 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.37375946 |
| 73 | Ventricular tachycardia (HP:0004756) | 2.37201217 |
| 74 | Obstructive sleep apnea (HP:0002870) | 2.35360570 |
| 75 | Ventricular fibrillation (HP:0001663) | 2.33951876 |
| 76 | Abnormal hair whorl (HP:0010721) | 2.31545146 |
| 77 | Abnormality of pain sensation (HP:0010832) | 2.31523728 |
| 78 | Impaired pain sensation (HP:0007328) | 2.31523728 |
| 79 | Ulnar deviation of the wrist (HP:0003049) | 2.29833322 |
| 80 | Lower limb amyotrophy (HP:0007210) | 2.28519796 |
| 81 | Abnormality of the calf musculature (HP:0001430) | 2.27815209 |
| 82 | Progressive inability to walk (HP:0002505) | 2.26944628 |
| 83 | Stridor (HP:0010307) | 2.26685134 |
| 84 | Impaired social interactions (HP:0000735) | 2.26179891 |
| 85 | Abnormal social behavior (HP:0012433) | 2.26179891 |
| 86 | Postural instability (HP:0002172) | 2.25770915 |
| 87 | EMG: neuropathic changes (HP:0003445) | 2.25098503 |
| 88 | Ulnar bowing (HP:0003031) | 2.24297796 |
| 89 | Bulbar palsy (HP:0001283) | 2.23881570 |
| 90 | Specific learning disability (HP:0001328) | 2.23482547 |
| 91 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.20815491 |
| 92 | Distal upper limb amyotrophy (HP:0007149) | 2.20616457 |
| 93 | Upper limb amyotrophy (HP:0009129) | 2.20616457 |
| 94 | Heart block (HP:0012722) | 2.20450541 |
| 95 | Postural tremor (HP:0002174) | 2.20439185 |
| 96 | Dysmetric saccades (HP:0000641) | 2.20128647 |
| 97 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.19760284 |
| 98 | Epileptiform EEG discharges (HP:0011182) | 2.17252329 |
| 99 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 2.17229992 |
| 100 | Hypoplasia of the brainstem (HP:0002365) | 2.17229992 |
| 101 | Inability to walk (HP:0002540) | 2.16663448 |
| 102 | Bradykinesia (HP:0002067) | 2.16457438 |
| 103 | Ragged-red muscle fibers (HP:0003200) | 2.16389185 |
| 104 | Status epilepticus (HP:0002133) | 2.15496156 |
| 105 | Myotonia (HP:0002486) | 2.14396845 |
| 106 | Protrusio acetabuli (HP:0003179) | 2.12730818 |
| 107 | Broad face (HP:0000283) | 2.12154553 |
| 108 | Impaired vibratory sensation (HP:0002495) | 2.11044914 |
| 109 | Akinesia (HP:0002304) | 2.10645866 |
| 110 | Progressive muscle weakness (HP:0003323) | 2.10076050 |
| 111 | Absent speech (HP:0001344) | 2.09249974 |
| 112 | Torticollis (HP:0000473) | 2.08481696 |
| 113 | Delusions (HP:0000746) | 2.07308965 |
| 114 | Hemorrhage of the eye (HP:0011885) | 2.06764159 |
| 115 | Gait ataxia (HP:0002066) | 2.06510606 |
| 116 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.05140848 |
| 117 | Focal dystonia (HP:0004373) | 2.05058964 |
| 118 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.04892401 |
| 119 | Calf muscle hypertrophy (HP:0008981) | 2.04810009 |
| 120 | Cholelithiasis (HP:0001081) | 2.03805879 |
| 121 | EEG with generalized epileptiform discharges (HP:0011198) | 2.02776847 |
| 122 | Hypoventilation (HP:0002791) | 2.01520991 |
| 123 | Abnormality of the vocal cords (HP:0008777) | 1.98211167 |
| 124 | Abnormality of the corticospinal tract (HP:0002492) | 1.97204588 |
| 125 | Neck muscle weakness (HP:0000467) | 1.96734640 |
| 126 | Genetic anticipation (HP:0003743) | 1.96617965 |
| 127 | Scapular winging (HP:0003691) | 1.95573442 |
| 128 | Hypsarrhythmia (HP:0002521) | 1.94604317 |
| 129 | Lymphangioma (HP:0100764) | 1.94312861 |
| 130 | Spinal rigidity (HP:0003306) | 1.93880701 |
| 131 | Hammertoe (HP:0001765) | 1.93607959 |
| 132 | Muscle fiber splitting (HP:0003555) | 1.92524512 |
| 133 | Abnormal gallbladder physiology (HP:0012438) | 1.91937486 |
| 134 | Cholecystitis (HP:0001082) | 1.91937486 |
| 135 | Thin ribs (HP:0000883) | 1.91219492 |
| 136 | Hypothermia (HP:0002045) | 1.90740195 |
| 137 | Gait imbalance (HP:0002141) | 1.90494846 |
| 138 | Lower limb muscle weakness (HP:0007340) | 1.90410838 |
| 139 | Testicular atrophy (HP:0000029) | 1.89827780 |
| 140 | Muscle stiffness (HP:0003552) | 1.88728374 |
| 141 | Annular pancreas (HP:0001734) | 1.88129542 |
| 142 | Flat acetabular roof (HP:0003180) | 1.87962503 |
| 143 | Sensory axonal neuropathy (HP:0003390) | 1.87894729 |
| 144 | Vertebral compression fractures (HP:0002953) | 1.87564317 |
| 145 | Dilated cardiomyopathy (HP:0001644) | 1.87052472 |
| 146 | Hypercortisolism (HP:0001578) | 1.87050280 |
| 147 | Resting tremor (HP:0002322) | 1.86991895 |
| 148 | Calcaneovalgus deformity (HP:0001848) | 1.86636552 |
| 149 | Abnormality of the foot musculature (HP:0001436) | 1.86431577 |
| 150 | Craniofacial dystonia (HP:0012179) | 1.86189987 |
| 151 | Insomnia (HP:0100785) | 1.84736312 |
| 152 | Incomplete penetrance (HP:0003829) | 1.84510287 |
| 153 | Hemiparesis (HP:0001269) | 1.84014677 |
| 154 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 1.83843652 |
| 155 | Rigidity (HP:0002063) | 1.83780200 |
| 156 | Distal arthrogryposis (HP:0005684) | 1.83705270 |
| 157 | Subaortic stenosis (HP:0001682) | 1.83334252 |
| 158 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.83334252 |
| 159 | Foot dorsiflexor weakness (HP:0009027) | 1.82885275 |
| 160 | Atrioventricular block (HP:0001678) | 1.82460184 |
| 161 | Steppage gait (HP:0003376) | 1.82151001 |
| 162 | Poor suck (HP:0002033) | 1.82075756 |
| 163 | Abnormality of the aortic arch (HP:0012303) | 1.80629818 |
| 164 | Abnormality of glycolysis (HP:0004366) | 1.80487506 |
| 165 | Back pain (HP:0003418) | 1.78888582 |
| 166 | Hypercholesterolemia (HP:0003124) | 1.78784812 |
| 167 | Thin bony cortex (HP:0002753) | 1.78255656 |
| 168 | Mutism (HP:0002300) | 1.76780240 |
| 169 | Sparse lateral eyebrow (HP:0005338) | 1.76675891 |
| 170 | Hemiplegia (HP:0002301) | 1.75121753 |
| 171 | Bronchomalacia (HP:0002780) | 1.75056323 |
| 172 | Bradycardia (HP:0001662) | 1.74951261 |
| 173 | Blue irides (HP:0000635) | 1.74456588 |
| 174 | Excessive salivation (HP:0003781) | 1.72993400 |
| 175 | Drooling (HP:0002307) | 1.72993400 |
| 176 | Genital tract atresia (HP:0001827) | 1.72853356 |
| 177 | Generalized amyotrophy (HP:0003700) | 1.71957783 |
| 178 | Retinal dysplasia (HP:0007973) | 1.71765428 |
| 179 | Stereotypic behavior (HP:0000733) | 1.71638916 |
| 180 | Abnormality of the tricuspid valve (HP:0001702) | 1.70932225 |
| 181 | Biconcave vertebral bodies (HP:0004586) | 1.68494694 |
| 182 | Hypoalphalipoproteinemia (HP:0003233) | 1.67115225 |
| 183 | Asymmetry of the thorax (HP:0001555) | 1.66504234 |
| 184 | Easy fatigability (HP:0003388) | 1.66118471 |
| 185 | Abnormal gallbladder morphology (HP:0012437) | 1.65231082 |
| 186 | Abnormality of the calcaneus (HP:0008364) | 1.64795070 |
| 187 | Ventricular arrhythmia (HP:0004308) | 1.64783149 |
| 188 | Infantile muscular hypotonia (HP:0008947) | 1.64451484 |
| 189 | Cerebral inclusion bodies (HP:0100314) | 1.63465319 |
| 190 | Hyperthyroidism (HP:0000836) | 1.63070788 |
| 191 | Xanthomatosis (HP:0000991) | 1.62038934 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 5.40322756 |
| 2 | NTRK3 | 4.47445149 |
| 3 | ICK | 3.77247142 |
| 4 | MAP3K9 | 3.45904784 |
| 5 | CASK | 3.33128681 |
| 6 | MAP3K4 | 3.23578536 |
| 7 | MAP3K12 | 3.21146421 |
| 8 | MINK1 | 3.03330148 |
| 9 | TTN | 2.96772487 |
| 10 | MAP2K7 | 2.93606543 |
| 11 | SIK1 | 2.86986792 |
| 12 | EPHA4 | 2.66278638 |
| 13 | CDK19 | 2.66040916 |
| 14 | DAPK2 | 2.55340697 |
| 15 | PKN2 | 2.52392576 |
| 16 | EEF2K | 2.34485028 |
| 17 | OBSCN | 2.21033659 |
| 18 | MAP2K4 | 2.19910530 |
| 19 | PAK6 | 2.17307656 |
| 20 | GRK5 | 2.03565121 |
| 21 | LMTK2 | 1.99936764 |
| 22 | EPHA2 | 1.89658041 |
| 23 | KSR2 | 1.88974841 |
| 24 | PLK2 | 1.85516380 |
| 25 | DAPK1 | 1.84986280 |
| 26 | SMG1 | 1.79462859 |
| 27 | ARAF | 1.78623803 |
| 28 | FGFR4 | 1.75727298 |
| 29 | RIPK1 | 1.74004290 |
| 30 | TESK1 | 1.70236448 |
| 31 | RIPK4 | 1.69532842 |
| 32 | NTRK1 | 1.68909856 |
| 33 | TESK2 | 1.62833458 |
| 34 | MARK1 | 1.62142781 |
| 35 | ERN1 | 1.60455872 |
| 36 | LATS2 | 1.49564873 |
| 37 | MAPK13 | 1.46643339 |
| 38 | CAMKK1 | 1.42022041 |
| 39 | MUSK | 1.40736927 |
| 40 | CDK5 | 1.38790151 |
| 41 | OXSR1 | 1.36670925 |
| 42 | CAMKK2 | 1.34615185 |
| 43 | IRAK3 | 1.33193883 |
| 44 | NTRK2 | 1.31283051 |
| 45 | MST1R | 1.28753397 |
| 46 | PRKD3 | 1.23198099 |
| 47 | PRPF4B | 1.20900248 |
| 48 | PRKCG | 1.20869907 |
| 49 | MARK2 | 1.19743312 |
| 50 | SIK3 | 1.18598960 |
| 51 | MTOR | 1.16558508 |
| 52 | MAPKAPK5 | 1.16380151 |
| 53 | UHMK1 | 1.15529599 |
| 54 | SGK223 | 1.11370484 |
| 55 | SGK494 | 1.11370484 |
| 56 | RET | 1.11325811 |
| 57 | AKT3 | 1.10892476 |
| 58 | CDK18 | 1.09778076 |
| 59 | KSR1 | 1.08851578 |
| 60 | PDGFRA | 1.07967185 |
| 61 | MAP3K2 | 1.06421370 |
| 62 | CDK14 | 1.06398013 |
| 63 | SGK2 | 1.05847787 |
| 64 | PTK2B | 1.04019197 |
| 65 | MAPK12 | 1.03247693 |
| 66 | NME2 | 1.02000894 |
| 67 | CDK15 | 1.01946940 |
| 68 | STK38 | 1.01145473 |
| 69 | PHKG1 | 1.00125219 |
| 70 | PHKG2 | 1.00125219 |
| 71 | PNCK | 0.99517198 |
| 72 | CDK12 | 0.98457442 |
| 73 | DMPK | 0.98033826 |
| 74 | PTK2 | 0.94050956 |
| 75 | CCNB1 | 0.92475248 |
| 76 | LIMK1 | 0.89962762 |
| 77 | CDK11A | 0.89162896 |
| 78 | PINK1 | 0.87199785 |
| 79 | CAMK2A | 0.86957036 |
| 80 | MAPKAPK3 | 0.85952595 |
| 81 | CAMK1D | 0.84721946 |
| 82 | MAP2K3 | 0.83244993 |
| 83 | WNK1 | 0.83021362 |
| 84 | CAMK2B | 0.77811141 |
| 85 | MET | 0.77765677 |
| 86 | SGK3 | 0.76948944 |
| 87 | PIM2 | 0.74621150 |
| 88 | MAPK11 | 0.74249656 |
| 89 | BRAF | 0.73962427 |
| 90 | ILK | 0.72666483 |
| 91 | PTK6 | 0.71831401 |
| 92 | MAP3K7 | 0.71372428 |
| 93 | CDK8 | 0.70880216 |
| 94 | NEK1 | 0.69394664 |
| 95 | TAOK1 | 0.69287981 |
| 96 | PDK4 | 0.69219372 |
| 97 | PDK3 | 0.69219372 |
| 98 | FES | 0.68970360 |
| 99 | PRKD2 | 0.68560714 |
| 100 | CAMK1 | 0.68435898 |
| 101 | STK39 | 0.68038906 |
| 102 | PRKCH | 0.67614480 |
| 103 | CAMK2G | 0.66748148 |
| 104 | AKT2 | 0.66149673 |
| 105 | CAMK2D | 0.66018265 |
| 106 | DYRK1B | 0.65321280 |
| 107 | PDPK1 | 0.64936047 |
| 108 | PDK1 | 0.64674455 |
| 109 | TNIK | 0.64393257 |
| 110 | CDK7 | 0.62392795 |
| 111 | RPS6KB2 | 0.62373840 |
| 112 | MAP2K6 | 0.62202921 |
| 113 | BMPR2 | 0.62053260 |
| 114 | BMX | 0.61574721 |
| 115 | TAOK2 | 0.61503914 |
| 116 | CDC42BPA | 0.60778228 |
| 117 | MAP2K1 | 0.60038414 |
| 118 | MAP2K2 | 0.59765276 |
| 119 | MAP3K6 | 0.58812506 |
| 120 | PRKAA1 | 0.57524698 |
| 121 | BCR | 0.56898705 |
| 122 | TSSK6 | 0.56672259 |
| 123 | STK11 | 0.56023762 |
| 124 | PAK4 | 0.55006369 |
| 125 | TNK2 | 0.54280577 |
| 126 | FER | 0.51383855 |
| 127 | PAK3 | 0.51244319 |
| 128 | CAMK1G | 0.51062700 |
| 129 | MAP3K1 | 0.51036344 |
| 130 | TYRO3 | 0.49819934 |
| 131 | RPS6KA2 | 0.49486191 |
| 132 | PRKD1 | 0.49267799 |
| 133 | WNK4 | 0.49255154 |
| 134 | LRRK2 | 0.48147437 |
| 135 | NEK6 | 0.47833290 |
| 136 | RPS6KL1 | 0.47800089 |
| 137 | RPS6KC1 | 0.47800089 |
| 138 | MAP3K13 | 0.47654863 |
| 139 | ADRBK1 | 0.45913951 |
| 140 | SIK2 | 0.43330341 |
| 141 | BRSK1 | 0.42854693 |
| 142 | DDR2 | 0.42695300 |
| 143 | RAF1 | 0.42356522 |
| 144 | DAPK3 | 0.42315547 |
| 145 | CSNK1G2 | 0.41549894 |
| 146 | PRKAA2 | 0.38750436 |
| 147 | PRKCE | 0.38429384 |
| 148 | SGK1 | 0.37842324 |
| 149 | CAMK4 | 0.36770082 |
| 150 | MAP3K11 | 0.36405550 |
| 151 | ROCK2 | 0.35875701 |
| 152 | ALK | 0.34351027 |
| 153 | NME1 | 0.33997824 |
| 154 | RPS6KA3 | 0.32778481 |
| 155 | MAPK10 | 0.31471010 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 4.36926459 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 3.40846444 |
| 3 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.24861337 |
| 4 | Olfactory transduction_Homo sapiens_hsa04740 | 3.23409985 |
| 5 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.60272130 |
| 6 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.53108725 |
| 7 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.46511811 |
| 8 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.44145510 |
| 9 | Circadian entrainment_Homo sapiens_hsa04713 | 2.41170027 |
| 10 | Long-term potentiation_Homo sapiens_hsa04720 | 2.39756985 |
| 11 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 2.36008237 |
| 12 | Sulfur relay system_Homo sapiens_hsa04122 | 2.33621486 |
| 13 | GABAergic synapse_Homo sapiens_hsa04727 | 2.27356357 |
| 14 | Taste transduction_Homo sapiens_hsa04742 | 2.26304739 |
| 15 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.25818036 |
| 16 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.23001993 |
| 17 | Morphine addiction_Homo sapiens_hsa05032 | 2.18742047 |
| 18 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 2.15508200 |
| 19 | Salivary secretion_Homo sapiens_hsa04970 | 2.10543643 |
| 20 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.09316175 |
| 21 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.08520710 |
| 22 | Insulin secretion_Homo sapiens_hsa04911 | 2.05928197 |
| 23 | Carbon metabolism_Homo sapiens_hsa01200 | 1.78718367 |
| 24 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.78455654 |
| 25 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.77687871 |
| 26 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.71731985 |
| 27 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.71218540 |
| 28 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.69986787 |
| 29 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.67202801 |
| 30 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.64283194 |
| 31 | Other glycan degradation_Homo sapiens_hsa00511 | 1.59508316 |
| 32 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.55036718 |
| 33 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.54898262 |
| 34 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.52218219 |
| 35 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.50108976 |
| 36 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.49988398 |
| 37 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.46696215 |
| 38 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.43457573 |
| 39 | Long-term depression_Homo sapiens_hsa04730 | 1.42607778 |
| 40 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.41009338 |
| 41 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.39570619 |
| 42 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.38899657 |
| 43 | Renin secretion_Homo sapiens_hsa04924 | 1.38239094 |
| 44 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.36769626 |
| 45 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.34360370 |
| 46 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.32222782 |
| 47 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.28666679 |
| 48 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.26078816 |
| 49 | Galactose metabolism_Homo sapiens_hsa00052 | 1.24861355 |
| 50 | Gap junction_Homo sapiens_hsa04540 | 1.17619846 |
| 51 | Cocaine addiction_Homo sapiens_hsa05030 | 1.15942514 |
| 52 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.15405792 |
| 53 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.14324419 |
| 54 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.14301700 |
| 55 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.13509337 |
| 56 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.13019701 |
| 57 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.12262919 |
| 58 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.11131227 |
| 59 | Parkinsons disease_Homo sapiens_hsa05012 | 1.08210193 |
| 60 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.07043739 |
| 61 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.07009354 |
| 62 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.06480070 |
| 63 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.03355652 |
| 64 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.02383193 |
| 65 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.02100893 |
| 66 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.99032913 |
| 67 | Glioma_Homo sapiens_hsa05214 | 0.98811277 |
| 68 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.97470691 |
| 69 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.97264125 |
| 70 | Alzheimers disease_Homo sapiens_hsa05010 | 0.97262213 |
| 71 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.93745672 |
| 72 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.92470444 |
| 73 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.91106020 |
| 74 | Lysine degradation_Homo sapiens_hsa00310 | 0.89341226 |
| 75 | Melanogenesis_Homo sapiens_hsa04916 | 0.87498178 |
| 76 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.86330644 |
| 77 | Axon guidance_Homo sapiens_hsa04360 | 0.84405797 |
| 78 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.83369123 |
| 79 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.83130254 |
| 80 | Phototransduction_Homo sapiens_hsa04744 | 0.78866556 |
| 81 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.78252458 |
| 82 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.77422587 |
| 83 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.76239553 |
| 84 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.75900875 |
| 85 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.75024211 |
| 86 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.73158915 |
| 87 | Insulin resistance_Homo sapiens_hsa04931 | 0.72005399 |
| 88 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.71030023 |
| 89 | Huntingtons disease_Homo sapiens_hsa05016 | 0.68235407 |
| 90 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.67449545 |
| 91 | Histidine metabolism_Homo sapiens_hsa00340 | 0.67373756 |
| 92 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.67323868 |
| 93 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.65447894 |
| 94 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.65274995 |
| 95 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.64223571 |
| 96 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.62631496 |
| 97 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.62473686 |
| 98 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.59927507 |
| 99 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.58556311 |
| 100 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.58290493 |
| 101 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.55794003 |
| 102 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.55444802 |
| 103 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.55353490 |
| 104 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.54802874 |
| 105 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.54273556 |
| 106 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.53934371 |
| 107 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.53835020 |
| 108 | Bladder cancer_Homo sapiens_hsa05219 | 0.53550271 |
| 109 | ABC transporters_Homo sapiens_hsa02010 | 0.53060338 |
| 110 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.52541674 |
| 111 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.52082944 |
| 112 | Tight junction_Homo sapiens_hsa04530 | 0.52052303 |
| 113 | Endocytosis_Homo sapiens_hsa04144 | 0.51920862 |
| 114 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.51349388 |
| 115 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.50320217 |
| 116 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.49304419 |
| 117 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.48792914 |
| 118 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.47723705 |
| 119 | Phagosome_Homo sapiens_hsa04145 | 0.47066928 |
| 120 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.47038325 |
| 121 | Focal adhesion_Homo sapiens_hsa04510 | 0.46719433 |
| 122 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.46068294 |
| 123 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.45758316 |
| 124 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.44939998 |
| 125 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.44739560 |
| 126 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.43578672 |
| 127 | Bile secretion_Homo sapiens_hsa04976 | 0.41796712 |
| 128 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.41357989 |
| 129 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.41255396 |
| 130 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.39493019 |
| 131 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.39467694 |
| 132 | Alcoholism_Homo sapiens_hsa05034 | 0.38038873 |
| 133 | Endometrial cancer_Homo sapiens_hsa05213 | 0.37204669 |
| 134 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.36570671 |
| 135 | Melanoma_Homo sapiens_hsa05218 | 0.35434359 |
| 136 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.34800001 |
| 137 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.34448069 |
| 138 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.33628603 |
| 139 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.31145788 |
| 140 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.29280126 |
| 141 | Mineral absorption_Homo sapiens_hsa04978 | 0.28558831 |
| 142 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.27926062 |
| 143 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.26000357 |
| 144 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.24503526 |
| 145 | Salmonella infection_Homo sapiens_hsa05132 | 0.24270132 |
| 146 | Prion diseases_Homo sapiens_hsa05020 | 0.23845386 |
| 147 | Thyroid cancer_Homo sapiens_hsa05216 | 0.23578201 |

